Skip to main content

BAKER BROS. ADVISORS LP

Position in DNLI — Denali Therapeutics Inc.

CIK 1263508 NEW YORK, NY

Position in DNLI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$71,648,544
+$10,038,260 QoQ
Shares Held
3,731,695
0.0% QoQ
Ownership
2.35%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. DNLI ranks #26 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $71,648,544 3,731,695
2025-12-31 $61,610,284 3,731,695
2025-09-30 $54,184,211 3,731,695
2025-06-30 $52,206,413 3,731,695
2025-03-31 $50,732,393 3,731,695
2024-12-31 $76,051,944 3,731,695
2024-09-30 $108,704,275 3,731,695
2024-06-30 $86,649,957 3,731,695
2024-03-31 $76,574,381 3,731,695
2023-12-31 $55,950,426 2,607,196
2023-09-30 $47,284,021 2,292,003
2023-06-30 $42,946,552 1,455,322
2023-03-31 $25,084,523 1,088,738
2022-12-31 $30,277,803 1,088,738
2022-09-30 $18,068,369 588,738
2022-06-30 $17,326,559 588,738
2022-03-31 $2,854,701 88,738
2021-12-31 $3,957,714 88,738
2021-09-30 $4,476,832 88,738
2021-06-30 $6,960,608 88,738
2021-03-31 $5,066,939 88,738
2020-12-31 $7,432,694 88,738
2020-09-30 $3,561,502 99,400
2020-06-30 $2,536,482 104,900
2020-03-31 $1,836,799 104,900